Agrawal et al. used mouse splenic dendritic cells exposed to LT in vitro and in vivo. They observed that when stimulated with lipopolysaccharide, dendritic cells did not upregulate costimulatory molecules, secreted greatly diminished amounts of proinflammatory cytokines, and did not effectively stimulate antigen-specific T cells in vivo. Injections of LT into mice induced a profound impairment of antigen-specific T-and B-cell immunity. In addition, they showed that LT caused impairment of phosphorylation of p38 and ERK1/2, which mediates the suppressive effects on dendritic cells.
"These data suggest a role for LT in suppressing host immunity during B. anthracis infections, and represent an immune evasion strategy, where a microbe targets MAP kinases in dendritic cells to disarm the immune response... LT or its derivatives may also represent potential therapeutic tools in the regulation of deleterious immune responses in autoimmunity or transplantation," conclude the authors.
